These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28649404)

  • 1. Comparative transcriptomic analysis of
    Castro J; França A; Bradwell KR; Serrano MG; Jefferson KK; Cerca N
    NPJ Biofilms Microbiomes; 2017; 3():3. PubMed ID: 28649404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
    Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
    Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment.
    Verstraelen H; Swidsinski A
    Curr Opin Infect Dis; 2013 Feb; 26(1):86-9. PubMed ID: 23221767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid.
    Patterson JL; Girerd PH; Karjane NW; Jefferson KK
    Am J Obstet Gynecol; 2007 Aug; 197(2):170.e1-7. PubMed ID: 17689638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis.
    Machado A; Cerca N
    J Infect Dis; 2015 Dec; 212(12):1856-61. PubMed ID: 26080369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of culture conditions for Gardnerella vaginalis biofilm formation.
    Machado D; Palmeira-de-Oliveira A; Cerca N
    J Microbiol Methods; 2015 Nov; 118():143-6. PubMed ID: 26381661
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Castro J; Rosca AS; Muzny CA; Cerca N
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33672647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
    Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
    Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors.
    Castro J; Machado D; Cerca N
    ISME J; 2019 May; 13(5):1306-1317. PubMed ID: 30670827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of novel endolysins targeting Gardnerella vaginalis biofilms to treat bacterial vaginosis.
    Arroyo-Moreno S; Cummings M; Corcoran DB; Coffey A; McCarthy RR
    NPJ Biofilms Microbiomes; 2022 Apr; 8(1):29. PubMed ID: 35440653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes.
    Patterson JL; Stull-Lane A; Girerd PH; Jefferson KK
    Microbiology (Reading); 2010 Feb; 156(Pt 2):392-399. PubMed ID: 19910411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.
    Algburi A; Zhang Y; Weeks R; Comito N; Zehm S; Pinto J; Uhrich KE; Chikindas ML
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity.
    Hooven TA; Randis TM; Hymes SR; Rampersaud R; Ratner AJ
    J Antimicrob Chemother; 2012 Dec; 67(12):2870-2. PubMed ID: 22855857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of virulence factors & biotypes of
    Nisha K; Antony B; Udayalaxmi J
    Indian J Med Res; 2019 Jan; 149(1):57-61. PubMed ID: 31115376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of Compounds against Gardnerella vaginalis Biofilms.
    Gottschick C; Szafranski SP; Kunze B; Sztajer H; Masur C; Abels C; Wagner-Döbler I
    PLoS One; 2016; 11(4):e0154086. PubMed ID: 27111438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the Anti-Biofilm Effect of the Engineered Phage Endolysin PM-477 to Disrupt In Vitro Single- and Dual-Species Biofilms of Vaginal Pathogens Associated with Bacterial Vaginosis.
    Castro J; Sousa LGV; França Â; Podpera Tisakova L; Corsini L; Cerca N
    Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology of bacterial vaginosis and polymicrobial biofilm formation.
    Jung HS; Ehlers MM; Lombaard H; Redelinghuys MJ; Kock MM
    Crit Rev Microbiol; 2017 Nov; 43(6):651-667. PubMed ID: 28358585
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Johnston W; Ware A; Kuiters WF; Delaney C; Brown JL; Hagen S; Corcoran D; Cummings M; Ramage G; Kean R
    Biofilm; 2023 Dec; 5():100101. PubMed ID: 36655001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model.
    Alves P; Castro J; Sousa C; Cereija TB; Cerca N
    J Infect Dis; 2014 Aug; 210(4):593-6. PubMed ID: 24596283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm and pathogenic factor analysis of
    Ma X; Wang X; Ye S; Liu J; Yuan H; Wang N
    Front Microbiol; 2022; 13():1033040. PubMed ID: 36619994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.